- Bioplus Acquisition Corp.
Bioplus Acquisition Corp.
260 Madison Avenue
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$10.00
20,000,000
Positive
High
71.36%
Offering Team
Deal Managers
- Cantor Fitzgerald
Lawyers
- Latham & Watkins LLP
Auditors
- WithumSmith+Brown, P.C
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Throughout this prospectus we will refer to this as our initial business combination. While our efforts to identify a target business may span many industries and regions worldwide, we intend to focus our search for More
Deal Tracker
Investors
Filing
01 Dec, 2021Offer
03 Dec, 2021Look Ahead
Lock Up Expiry
03 Jun, 2022Earning
Nov 1, 2018IPO Terms
Offer Price | $10.00 |
Offer Size | 20M |